Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Inhaled NO as an Anti-Inflammatory and Anti-Reperfusion Agent in Infants and Children Undergoing Cardiopulmonary Bypass
This study is currently recruiting participants.
Study NCT00585013 Information provided by Washington University School of Medicine
First Received: December 20, 2007 Last Updated: December 10, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Congenital Heart Disease
Systemic Inflammatory Response
Additional conditions recognized in this trial
Heart Defects, Congenital
Heart Diseases
More general conditions related to this trial
Cardiovascular Abnormalities
Cardiovascular Diseases
Congenital Abnormalities
Interventions listed in this trial
Nitric Oxide
More general drug interventions related to this trial
Anti-Asthmatic Agents
Antioxidants
Autonomic Agents
Bronchodilator Agents
Cardiovascular Agents
Endothelium-Dependent Relaxing Factors
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Washington University School of Medicine
INO Therapeutics
Back to top of Main Content
